NEW YORK (GenomeWeb News) – Genetic test developer DxNA said today that the US Food and Drug Administration has granted Emergency Use Authorization (EUA) for the firm's PCR-based test for 2009 H1N1 influenza.

The EUA for DxNA's GeneSTAT detection platform is a legal means that allows FDA to authorize new medical devices during medical emergencies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.